FDA Adverse Event Malfunction Summary report: N

GREENLIGHT MOXY FIBER OPTIC

MDR report key: 17993166 · Received October 23, 2023

Report

Report Number
2124215-2023-58717
Event Type
Malfunction
Date Received
October 23, 2023
Date of Event
October 3, 2023
Report Date
December 26, 2023
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
GEX
UDI-DI
00878953005515
PMA / PMN Number
K120870
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TW
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

UPON RECEIPT AT OUR QUALITY ASSURANCE LABORATORY, THE RETURNED FIBER UNDERWENT A THOROUGH ANALYSIS. VISUAL ANALYSIS OF THE RETURNED FIBER IDENTIFIED THAT THE CONNECTOR CONE, SEGMENTS, AND TABS APPEAR IN GOOD CONDITION AND SECURED. THE CONTROL KNOB IS ATTACHED AND ALIGNED WITH FIBER AND CAN ROTATE THE FIBER. A DISTAL CIRCUMFERENTIAL FRACTURE WAS OBSERVED AT THE GLASS CAP. FUNCTIONAL TESTING WITH THE HENE (HELIUM-NEON) LASER FIXTURE DID NOT IDENTIFY BREAKS ALONG THE LENGTH OF THE FIBER. THE FIBER WAS TESTED USING THE FORWARD FIRING TEST FIXTURE, THE CALCULATED THE RATE OF FORWARD FIRING WAS BELOW THE THRESHOLD FOR POTENTIAL PATIENT HARM. BASED ON ANALYSIS RESULT, THE INTERACTION BETWEEN THE USER AND DEVICE CAUSED OR CONTRIBUTED TO THE OBSERVED FIBER DAMAGE.

Description of Event or Problem · 0

IT WAS REPORTED THAT AFTER 34 MIN OF PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE (PVP) AND 222106 JOULES USED, THE FIBER STARTED TO FORWARD FIRE. A SECOND FIBER WAS USED TO COMPLETE THE PROCEDURE. NO PATIENT COMPLICATIONS WERE REPORTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT AFTER 34 MIN OF PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE (PVP) AND 222106 JOULES USED, THE FIBER STARTED TO FORWARD FIRE. A SECOND FIBER WAS USED TO COMPLETE THE PROCEDURE. NO PATIENT COMPLICATIONS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1674376 GREENLIGHT MOXY FIBER OPTIC POWERED LASER SURGICAL INSTRUMENT GEX BOSTON SCIENTIFIC CORPORATION 0010-2400 0031044051 00878953005515

Patients

Seq Age Sex Outcome Treatment
1 Male